Investigating home blood pressure variability and its effects on heart and metabolic health in hypertensive patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study examines the relationship between home blood pressure variability (BPV) and arteriosclerosis, as well as metabolic dysfunction in hypertensive patients over a three-year period. Utilizing the Healthscan mobile application, participants will record their daily blood pressure readings, allowing researchers to analyze the predictive value of BPV for major adverse cardiovascular events (MACE) such as heart attacks and strokes. The study aims to validate the importance of home BP monitoring in managing hypertension and understanding its impact on cardiovascular and metabolic health.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Adults aged 19 years or older.
2. Diagnosed with hypertension.
3. Regular use of antihypertensive medication for at least two years.
4. Access to a home blood pressure monitor.
5. Comprehensive medical records available for the past year.

Exclusion Criteria:

1\. Participants who are unable to consent or who might not reliably use the home monitoring app.

Where it's running

• Korea University Anam Hospital
  Seoul, South Korea Recruiting
• Korea Univeristy Guro Hospital
  Seoul, South Korea Recruiting

Study contacts

• Principal investigator: Hyung Joon Joo, MD PhD — Korea University Anam Hospital
• Study coordinator: Ji Hyeon Baek, BSN
• Email: jh2bac@gmail.com
• Phone: 82-2-920-5445

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using low-dose aspirin after preeclampsia to improve recovery

  This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.

  Recruiting Phase 4 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT06281665

• IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension

  This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.

  Recruiting at 8 sites Bahir Dar University · Ādēt and 7 other locations · NCT07894068

• Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF

  This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.

  Recruiting London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · London, Ontario · NCT07893821

• Hypertension: Does Education Help Patients Manage Blood Pressure Better?

  This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.

  Recruiting Inonu University · Batman, Center · NCT07890090

• High BMI and periodontitis in Thai adults under 60

  This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.

  Recruiting Mahidol University · Bangkok, Ratchathewi · NCT07880717

• Long-term GW906 treatment for people with essential hypertension

  This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.

  Recruiting Shenzhen Salubris Pharmaceuticals Co., Ltd. · Shanghai, Shanghai Municipality · NCT07879755

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.